Beatriz Rodríguez-Miquel

Statistics

Publications

Citations

159

H-Index

Active since

2019

Affiliations

GlaxoSmithKline (Spain)(Current)

University of Oxford

Beatriz Rodríguez-Miquel is an author at GlaxoSmithKline (Spain) specializing in mycobacterium tuberculosis pathogenesis, enzymology, and molecular biology.

ORCID

Publications per year

2019–2023

Publications

Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence

Noton K. Dutta, Lee G. Klinkenberg, Maria-Jesus Vazquez et al. · Science Advances · 2019 · 134 citations · Full text

Life Sciences, Microbiology, Molecular Biology +10

High-throughput screen with the <scp>l,d</scp>-transpeptidase LdtMt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors

Mariska de Munnik, Pauline A. Lang, Francisco De Dios Anton et al. · Chemical Science · 2023 · 15 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +11

αβ,α′β′-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes

Mariska de Munnik, Jasper Lithgow, Lennart Brewitz et al. · Chemical Communications · 2023 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–3 of 3